BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16626928)

  • 1. Development of a novel three-dimensional in vitro model of oral Candida infection.
    Dongari-Bagtzoglou A; Kashleva H
    Microb Pathog; 2006 Jun; 40(6):271-8. PubMed ID: 16626928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia for the study of host-pathogen interactions.
    Schaller M; Weindl G
    Methods Mol Biol; 2009; 470():327-45. PubMed ID: 19089393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epithelial model systems for the study of Candida infections in vitro: part II. Histologic methods for studying fungal invasion.
    Hernandez R; Rupp S
    Methods Mol Biol; 2009; 470():105-23. PubMed ID: 19089380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tissue engineered models of the oral mucosa to investigate oral candidiasis.
    Yadev NP; Murdoch C; Saville SP; Thornhill MH
    Microb Pathog; 2011 Jun; 50(6):278-85. PubMed ID: 21296654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis.
    Bartie KL; Williams DW; Wilson MJ; Potts AJ; Lewis MA
    Oral Microbiol Immunol; 2004 Oct; 19(5):293-6. PubMed ID: 15327640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium.
    Silva S; Henriques M; Hayes A; Oliveira R; Azeredo J; Williams DW
    J Oral Pathol Med; 2011 May; 40(5):421-7. PubMed ID: 21158929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and ex vivo assays of virulence in Candida albicans.
    Calderone RA
    Methods Mol Biol; 2009; 499():85-93. PubMed ID: 19152042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents.
    Ohnemus U; Willers C; Bubenheim M; Horstkotte MA; Houdek P; Fischer F; Schmage P; Moll I; Brandner JM
    Mycoses; 2008 Jan; 51(1):21-9. PubMed ID: 18076591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Candida albicans infection of an in vitro oral epithelial model using confocal laser scanning microscopy.
    Malic S; Hill KE; Ralphs JR; Hayes A; Thomas DW; Potts AJ; Williams DW
    Oral Microbiol Immunol; 2007 Jun; 22(3):188-94. PubMed ID: 17488445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of interleukin-18 in the inflammatory response against oropharyngeal candidiasis.
    Tardif F; Goulet JP; Zakrazewski A; Chauvin P; Rouabhia M
    Med Sci Monit; 2004 Aug; 10(8):BR239-49. PubMed ID: 15277983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to Candida albicans in models of in vitro reconstituted human oral epithelium.
    Wagener J; Mailänder-Sanchez D; Schaller M
    Methods Mol Biol; 2012; 845():333-44. PubMed ID: 22328385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of the transcriptional repressor NRG1 accounts for altered host-cell interactions in Candida albicans and Candida dubliniensis.
    Moran GP; MacCallum DM; Spiering MJ; Coleman DC; Sullivan DJ
    Mol Microbiol; 2007 Nov; 66(4):915-29. PubMed ID: 17927699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral epithelium-Candida glabrata interactions in vitro.
    Li L; Dongari-Bagtzoglou A
    Oral Microbiol Immunol; 2007 Jun; 22(3):182-7. PubMed ID: 17488444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the Porcine Intestinal Epithelium (PIE)-Assay to analyze early stages of colonization by the human fungal pathogen Candida albicans.
    Wendland J; Hellwig D; Walther A; Sickinger S; Shadkchan Y; Martin R; Bauer J; Osherov N; Tretiakov A; Saluz HP
    J Basic Microbiol; 2006; 46(6):513-23. PubMed ID: 17139615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida glabrata and Candida albicans; dissimilar tissue tropism and infectivity in a gnotobiotic model of mucosal candidiasis.
    Westwater C; Schofield DA; Nicholas PJ; Paulling EE; Balish E
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):134-9. PubMed ID: 17854475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of candidiasis.
    Clancy CJ; Cheng S; Nguyen MH
    Methods Mol Biol; 2009; 499():65-76. PubMed ID: 19152040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic profiling of serologic response to Candida albicans during host-commensal and host-pathogen interactions.
    Pitarch A; Nombela C; Gil C
    Methods Mol Biol; 2009; 470():369-411. PubMed ID: 19089396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1alpha, IL-1ra and IL-8 are differentially induced by Candida in experimental oral candidiasis.
    Jayatilake JA; Samaranayake LP; Lu Q; Jin LJ
    Oral Dis; 2007 Jul; 13(4):426-33. PubMed ID: 17577331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.
    Jayatilake JA; Samaranayake YH; Cheung LK; Samaranayake LP
    J Oral Pathol Med; 2006 Sep; 35(8):484-91. PubMed ID: 16918600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models.
    Li L; Kashleva H; Dongari-Bagtzoglou A
    Microb Pathog; 2007 Apr; 42(4):138-47. PubMed ID: 17306958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.